Chitosans as absorption enhancers for poorly absorbable drugs 2: mechanism of absorption enhancement. 1997

N G Schipper, and S Olsson, and J A Hoogstraate, and A G deBoer, and K M Vårum, and P Artursson
Department of Pharmaceutics, Uppsala University, Biomedical Center, Sweden. Nicolaas.Schipper@eu.pnu.com

OBJECTIVE It has recently been shown that the absorption enhancing and toxic effects of chitosans are dependent on their chemical composition. In this study, the mechanisms underlying these effects were investigated at the cellular level. METHODS The effects on epithelial cells of chitosans with different chemical composition, absorption enhancing properties and toxicities were studied in Caco-2 monolayers. Chitosan C( 1:31) has a low degree of acetylation (DA) (1%) and a low m.w. (31 kD), and displays dose-dependent absorption enhancement and cytotoxicity; chitosan C(35:170) has a higher DA (35%) and a higher m.w. (170 kD), is less dose-dependent in absorption enhancement, and is not cytotoxic. A third non-toxic chitosan C(49:22) with a high DA (49%), a low m.w. (22 kD), and no influence on epithelial permeability was used as control. RESULTS C(1:31) and C(35:170) bound tightly to the epithelium. Cellular uptake of the chitosans was not observed. Both chitosans increased apical but not basolateral cell membrane permeability and induced a redistribution of cytoskeletal F-actin and the tight junction protein ZO-1. This resulted in increased paracellular permeability of hydrophilic marker molecules of different molecular weights. Addition of negatively charged heparin inhibited the cellular and the absorption enhancing effects of the chitosans, indicating that these effects are mediated via their positive charges. The onset of the effects of C(35:170) on apical membrane permeability and tight junction structure was much faster than that of C(1:31). C(49:22) did not influence any of the properties of the Caco-2 cell monolayers studied. CONCLUSIONS The binding and absorption enhancing effects of chitosans on epithelial cells are mediated through their positive charges. The interaction of chitosans with the cell membrane results in a structural reorganisation of tight junction-associated proteins which is followed by enhanced transport through the paracellular pathway.

UI MeSH Term Description Entries
D007408 Intestinal Absorption Uptake of substances through the lining of the INTESTINES. Absorption, Intestinal
D007413 Intestinal Mucosa Lining of the INTESTINES, consisting of an inner EPITHELIUM, a middle LAMINA PROPRIA, and an outer MUSCULARIS MUCOSAE. In the SMALL INTESTINE, the mucosa is characterized by a series of folds and abundance of absorptive cells (ENTEROCYTES) with MICROVILLI. Intestinal Epithelium,Intestinal Glands,Epithelium, Intestinal,Gland, Intestinal,Glands, Intestinal,Intestinal Gland,Mucosa, Intestinal
D010539 Permeability Property of membranes and other structures to permit passage of light, heat, gases, liquids, metabolites, and mineral ions. Permeabilities
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002686 Chitin A linear polysaccharide of beta-1->4 linked units of ACETYLGLUCOSAMINE. It is the second most abundant biopolymer on earth, found especially in INSECTS and FUNGI. When deacetylated it is called CHITOSAN.
D015415 Biomarkers Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc. Biochemical Markers,Biological Markers,Biomarker,Clinical Markers,Immunologic Markers,Laboratory Markers,Markers, Biochemical,Markers, Biological,Markers, Clinical,Markers, Immunologic,Markers, Laboratory,Markers, Serum,Markers, Surrogate,Markers, Viral,Serum Markers,Surrogate Markers,Viral Markers,Biochemical Marker,Biologic Marker,Biologic Markers,Clinical Marker,Immune Marker,Immune Markers,Immunologic Marker,Laboratory Marker,Marker, Biochemical,Marker, Biological,Marker, Clinical,Marker, Immunologic,Marker, Laboratory,Marker, Serum,Marker, Surrogate,Serum Marker,Surrogate End Point,Surrogate End Points,Surrogate Endpoint,Surrogate Endpoints,Surrogate Marker,Viral Marker,Biological Marker,End Point, Surrogate,End Points, Surrogate,Endpoint, Surrogate,Endpoints, Surrogate,Marker, Biologic,Marker, Immune,Marker, Viral,Markers, Biologic,Markers, Immune
D048271 Chitosan Deacetylated CHITIN, a linear polysaccharide of deacetylated beta-1,4-D-glucosamine. It is used in HYDROGEL and to treat WOUNDS. Poliglusam

Related Publications

N G Schipper, and S Olsson, and J A Hoogstraate, and A G deBoer, and K M Vårum, and P Artursson
August 1999, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences,
N G Schipper, and S Olsson, and J A Hoogstraate, and A G deBoer, and K M Vårum, and P Artursson
November 1996, Pharmaceutical research,
N G Schipper, and S Olsson, and J A Hoogstraate, and A G deBoer, and K M Vårum, and P Artursson
September 2010, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
N G Schipper, and S Olsson, and J A Hoogstraate, and A G deBoer, and K M Vårum, and P Artursson
January 2011, Journal of controlled release : official journal of the Controlled Release Society,
N G Schipper, and S Olsson, and J A Hoogstraate, and A G deBoer, and K M Vårum, and P Artursson
March 2017, Drug development and industrial pharmacy,
N G Schipper, and S Olsson, and J A Hoogstraate, and A G deBoer, and K M Vårum, and P Artursson
August 2018, Molecules (Basel, Switzerland),
N G Schipper, and S Olsson, and J A Hoogstraate, and A G deBoer, and K M Vårum, and P Artursson
March 2000, International journal of pharmaceutics,
N G Schipper, and S Olsson, and J A Hoogstraate, and A G deBoer, and K M Vårum, and P Artursson
June 2006, Drug metabolism and pharmacokinetics,
N G Schipper, and S Olsson, and J A Hoogstraate, and A G deBoer, and K M Vårum, and P Artursson
January 2014, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
N G Schipper, and S Olsson, and J A Hoogstraate, and A G deBoer, and K M Vårum, and P Artursson
October 2014, The Journal of pharmacy and pharmacology,
Copied contents to your clipboard!